The Role of Topical Immune Response Modifiers in Skin Cancer

Author： Woodmansee Courtney   Pillow Jessica   Skinner Robert B.  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.66, Iss.13, 2006-01, pp. : 1657-1664

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Imiquimod: an immune response modifier in the treatment of precancerous skin lesions and skin cancer

By Papadavid Evangelia   Stratigos Alexandros J   Falagas Matthew E  

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 11, 2007-08 ,pp. : 1743-1755

Informa Healthcare

Access to resources Recommend Favorite

Treating skin cancer with topical cream

By Micali Giuseppe   Lacarrubba Francesco   Dinotta Franco   Massimino Doriana   Nasca Maria Rita  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 9, 2010-06 ,pp. : 1515-1527

Informa Healthcare

Access to resources Recommend Favorite

Immune Therapy for Infectious Diseases at the Dawn of the 21st Century: the Past, Present and Future Role of Antibody Therapy, Therapeutic Vaccination and Biological Response Modifiers

By  

Current Pharmaceutical Design, Vol. 9, Iss. 12, 2003-05 ,pp. : 945-968

Bentham Science Publishers

Access to resources Recommend Favorite

The small-molecule immune response modifier imiquimod – its mode of action and clinical use in the treatment of skin cancer

By Schön Michael P   Schön Margarete  

Expert Opinion on Therapeutic Targets, Vol. 10, Iss. 1, 2006-02 ,pp. : 69-76

Informa Healthcare

Access to resources Recommend Favorite

Application of Nano- and Micro-Particles on the Topical Therapy of Skin-Related Immune Disorders

By  

Current Pharmaceutical Design, Vol. 21, Iss. 19, 2015-06 ,pp. : 2643-2667

Bentham Science Publishers

Access to resources Recommend Favorite